TQS structure
|
Common Name | TQS | ||
---|---|---|---|---|
CAS Number | 353483-92-8 | Molecular Weight | 376.47100 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C22H20N2O2S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of TQSTQS is a α7 nicotinic acetylcholine receptor (nAChR) positive allosteric modulator. TQS can be used for the research of neuroinflammatory pain[1]. |
Name | 4-(1-Naphthyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-s ulfonamide |
---|---|
Synonym | More Synonyms |
Description | TQS is a α7 nicotinic acetylcholine receptor (nAChR) positive allosteric modulator. TQS can be used for the research of neuroinflammatory pain[1]. |
---|---|
Related Catalog | |
Target |
nAChR[1] |
In Vivo | TQS (1 or 4 mg/kg; i.p.) reduces the expression of LPS-induced IκB mRNA, CD11b mRNA and regulates microglial morphological changes in the hippocampus[1]. Animal Model: Male C57BL/6J mice[1] Dosage: 1 or 4 mg/kg Administration: I.p. Result: Reduced the expression of LPS-induced IκB mRNA, CD11b mRNA and regulated microglial morphological changes in the hippocampus. |
References |
Molecular Formula | C22H20N2O2S |
---|---|
Molecular Weight | 376.47100 |
Exact Mass | 376.12500 |
PSA | 80.57000 |
LogP | 6.23280 |
Hazard Codes | Xi |
---|
PSB 11 hydrochloride |